The Mre11 complex: linking recombination to checkpoints

Mre11 复合体:将重组与检查点联系起来

基本信息

  • 批准号:
    7151945
  • 负责人:
  • 金额:
    $ 51.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-05-01 至 2007-12-02
  • 项目状态:
    已结题

项目摘要

In this proposal, we will continue to exploit the mouse strains established in the first funding period to address the mechanisms of the Mre11 complex's actions in chromosome metabolism. In addition, we will test the hypothesis that proteins interacting with the Nbs1 N terminus are critical for regulation of DNA damage responses. We expect that these approaches will continue to provide important insights regarding the role of the Mre11 complex in the maintenance of genomic integrity and the suppression of malignancy. The governing hypothesis of this proposal is that, from its association with chromatin, the Mre11 complex functions as a hub of the DNA damage response. We propose that this association is a prerequisite for its influence on sister chromatid interaction during DSB repair and DNA damage signaling. In addition, we propose that its signaling function takes place via protein interactions that include those governed by the N terminus of Nbs1. We will test these hypotheses through a combination of biochemical and genetic approaches in human cells and mice.
在本提案中,我们将继续利用第一个资助期建立的小鼠品系,以解决Mre 11复合物在染色体代谢中的作用机制。此外,我们将测试的假设,即蛋白质相互作用的Nbs1 N末端的DNA损伤反应的调节是至关重要的。我们希望这些方法将继续提供重要的见解Mre11复合物在维持基因组完整性和抑制恶性肿瘤的作用。该提议的主导假设是,从其与染色质的关联来看,Mre 11复合物作为DNA损伤反应的中心发挥作用。我们认为,这种关联是其影响DSB修复和DNA损伤信号传导过程中姐妹染色单体相互作用的先决条件。此外,我们提出,它的信号传导功能发生通过蛋白质相互作用,包括那些由N末端的Nbs1。我们将通过在人类细胞和小鼠中结合生物化学和遗传学方法来测试这些假设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John HJ Petrini其他文献

John HJ Petrini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John HJ Petrini', 18)}}的其他基金

DNA Damage & DNA Replication: a Complex Relationship
DNA损伤
  • 批准号:
    10799031
  • 财政年份:
    2020
  • 资助金额:
    $ 51.77万
  • 项目类别:
DNA Damage & DNA Replication: a Complex Relationship
DNA损伤
  • 批准号:
    10221003
  • 财政年份:
    2020
  • 资助金额:
    $ 51.77万
  • 项目类别:
DNA Damage & DNA Replication: a Complex Relationship
DNA损伤
  • 批准号:
    10657465
  • 财政年份:
    2020
  • 资助金额:
    $ 51.77万
  • 项目类别:
DNA Damage & DNA Replication: a Complex Relationship
DNA损伤
  • 批准号:
    10449117
  • 财政年份:
    2020
  • 资助金额:
    $ 51.77万
  • 项目类别:
FASEB SRC on Genetic Recombination and Genome Rearrangements
FASEB SRC 关于基因重组和基因组重排
  • 批准号:
    8199893
  • 财政年份:
    2011
  • 资助金额:
    $ 51.77万
  • 项目类别:
Project 3: Oncogene Activation and DNA Damage Response-Mediated Epigenetic Changes
项目3:癌基因激活和DNA损伤反应介导的表观遗传变化
  • 批准号:
    10132252
  • 财政年份:
    2000
  • 资助金额:
    $ 51.77万
  • 项目类别:
P95--LINKING DSB REPAIR AND CELL CYCLE CHECKPOINTS
P95——连接 DSB 修复和细胞周期检查点
  • 批准号:
    6386489
  • 财政年份:
    1999
  • 资助金额:
    $ 51.77万
  • 项目类别:
P95--LINKING DSB REPAIR AND CELL CYCLE CHECKPOINTS
P95——连接 DSB 修复和细胞周期检查点
  • 批准号:
    6182188
  • 财政年份:
    1999
  • 资助金额:
    $ 51.77万
  • 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
  • 批准号:
    7737365
  • 财政年份:
    1999
  • 资助金额:
    $ 51.77万
  • 项目类别:
Regulation of the DNA damage response by the Mre11 complex
Mre11 复合物对 DNA 损伤反应的调节
  • 批准号:
    8415942
  • 财政年份:
    1999
  • 资助金额:
    $ 51.77万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.77万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了